India’s Aurobindo Pharma has notified that it has secured tentative approval from US Food and Drug Administration (USFDA) for marketing generic lopinavir/ritonavir tablets.
It should be noted that the drug are generic equivalent of Abbott Laboratories' (ABT) Kaletra tablets and falls under anti-retrovial (ARV) segment.
The drugs are prescribed for the treatment of HIV-1 infection in adults and children above the age of two years. The tablets are used together with other anti-retroviral agents.